Concepedia

Peng Yong

PY

Statistics

Publications

8

Citations

294

H-Index

8

Active since

1997

Affiliations

Bristol-Myers Squibb (United States)(Current)

Zhejiang University

Biopharma Technology (United Kingdom)

Peng Yong is an author at Bristol-Myers Squibb (United States) specializing in medicine, natural sciences, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1997–2018

8

Publications

8

Implementation of Feedback-Guided Voluntary Breath-Hold Gating for Cone Beam CT-Based Stereotactic Body Radiotherapy

Peng Yong, Sastry Vedam, Joe Y. Chang et al. · International Journal of Radiation Oncology*Biology*Physics · 2011 · 52 citations

, , +7

SIRT2 suppresses non-small cell lung cancer growth by targeting JMJD2A

Weihua Xu, Kanqiu Jiang, Mingjing Shen et al. · Biological Chemistry · 2015 · 49 citations

Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R–YAP Axis

Hong Zhu, Dandan Wang, Tao Yuan et al. · Cancer Research · 2018 · 49 citations

CT-707, a Novel FAK Inhibitor, Synergizes with Cabozantinib to Suppress Hepatocellular Carcinoma by Blocking Cabozantinib-Induced FAK Activation

Dandan Wang, Ying Chen, Zibo Chen et al. · Molecular Cancer Therapeutics · 2016 · 46 citations

Minimally invasive thoracoscopically assisted coronary artery bypass surgery

Michael J. Mack, Tea E. Acuff, Peng Yong et al. · European Journal of Cardio-Thoracic Surgery · 1997 · 38 citations · Full text

1–5 of 8